Cellectis (CLLS) Exits Two CAR-T Programs. Can Gene Editing Justify the Clinical Reset?
finance.yahoo.com
17.09.2026 07:16
1 views
Related stories
Software glitch caused travel chaos, says air traffic control body
bbc.co.uk · 18.09
British Steel plan lacks credibility, MPs say
bbc.co.uk · 18.09
Why mortgage bonds are set to deteriorate, and possibly hit the whole market, according to this Wall Street expert
marketwatch.com · 18.09
Turkey moves to liquidate funds at centre of ‘Ponzi-like scheme’
ft.com · 18.09
Japan raises interest rates to 31-year high as central bankers fight inflation; retail sales rise in Great Britain – business live
theguardian.com · 18.09
Warren Buffett steps down as chair of Berkshire Hathaway after over 50 years
theguardian.com · 18.09